ArticlePharmacogenomics2014
Warfarin pharmacogenetic trials: is there a future for pharmacogenetic-guided dosing?
Article in Pharmacogenomics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- In Vivo Functional Effects ofDrug metabolism and disposition: the biological fate of chemicals · 2021Article
- Nonalcoholic fatty liver disease impacts the control of the international normalized ratio in patients with atrial fibrillation.Annals of translational medicine · 2020Article
- A path to precision in the ICU.Critical care (London, England) · 2017Review
- STRATEGIES FOR EQUITABLE PHARMACOGENOMIC-GUIDED WARFARIN DOSING AMONG EUROPEAN AND AFRICAN AMERICAN INDIVIDUALS IN A CLINICAL POPULATION.Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing · 2017Article
- Implementing Algorithm-Guided Warfarin Dosing in an Ethnically Diverse Patient Population Using Electronic Health Records and Preemptive CYP2C9 and VKORC1 Genetic Testing.Clinical pharmacology and therapeutics · 2016Article
- Other side of the coin for personalised medicine and healthcare: content analysis of 'personalised' practices in the literature.BMJ open · 2016Article
- Contrasting Medical and Legal Standards of Evidence: A Precision Medicine Case Study.The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2016Article
- Genes affecting warfarin response-interactive or additive?Journal of clinical pharmacology · 2015Article
- Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans.Pharmacogenetics and genomics · 2015Article
- Revisiting Warfarin Dosing Using Machine Learning Techniques.Computational and mathematical methods in medicine · 2015Article
- Closing the gap between knowledge and clinical application: challenges for genomic translation.PLoS genetics · 2015Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.